Can national health insurance to cover Revlimid?

Patients with multiple myeloma have pinned high hopes that Revlimid (lenalidomide) may be covered by national health insurance this year as the recent survey showed that a number of people want more high-priced cancer drug to be included in an insurance list.

Celgene's multiple myeloma drug was finally rejected by the National health Insurance Corporation as too expensive last year.

Howev...